AFFIMER XT

Dead / Abandoned — Abandoned — no statement of use filed (as of 04 Jul 2022)

What this means for you

This application is over — abandoned 04 Jul 2022. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.

Record

Serial number
87937170
Mark type
Stylized text
Filed
25 May 2018
Published for opposition
07 Apr 2020
Abandoned
04 Jul 2022
Attorney of record
Alexandra MacKay

Goods and services

  • Class 005 — Pharmaceuticals: Reagents for use in veterinary and medical diagnostic tests except tests in the field of immunohematology and transfusion medicine; reagents for use in medical and veterinary research except tests in the field of immunohematology and transfusion medicine; diagnostic reagents for use in medical and veterinary screening except tests in the field of immunohematology and transfusion medicine; diagnostic reagents for medical and veterinary diagnostic purposes for use in assays of biological samples, particularly blood except tests in the field of immunohematology and transfusion medicine; diagnostic reagents for medical and veterinary diagnostic purposes for use in assays of samples, particularly blood except tests in the field of immunohematology and transfusion medicine; diagnostic preparations for medical and veterinary diagnostic purposes for use in relation to food intolerance testing; pharmaceutical substances based on affinity reagents equivalent to antibodies, and products comprising them, all for use in medical and/or veterinary screening except tests in the field of immunohematology and transfusion medicine; pharmaceutical preparations in the nature of antigens for medical diagnostic use and veterinary diagnostic use and/or pharmaceutical purposes for the detection of cancer, inflammatory diseases, food allergies, infections, autoimmune disorders and for immunity testing but not immunohemotology and transfusion medicine; diagnostic and/or pharmaceutical preparations containing antigens except preparations in the field of immunohematology and transfusion medicine, for use in medical and veterinary treatment in the nature of anti-infectives, cancer immunotherapies, anti-inflammatory diseases, and genetic conditions; pharmaceutical preparation in the nature of substrates impregnated with or carrying antigens for medical diagnostic use and veterinary diagnostic use and pharmaceutical purposes other than immunohematology and transfusion medicine for the detection of cancers, inflammatory diseases, food allergies, infections, autoimmune disorders and for immunity testing; affinity reagents, namely, protein binding agents equivalent to antibodies for medical diagnostic use and veterinary diagnostic use and/or pharmaceutical purposes for the detection of cancers, inflammatory diseases, food allergies, infections, autoimmune disorders and for immunity testing but not immunohematology and transfusion medicine; pharmaceutical or diagnostic preparations containing affinity reagents, namely, protein binding agents equivalent to antibodies except in connection with immunohematology or transfusion medicine for medical diagnostic use and veterinary diagnostic use in the nature of anti-infectives, cancer immunotherapies, anti-inflammatory diseases and genetic conditions; pharmaceutical preparations in the nature of substrates impregnated with or carrying affinity reagents, namely, protein binding agents equivalent to antibodies for medical diagnostic use and veterinary diagnostic use in the nature of anti-infectives, cancer immunotherapies, anti-inflammatory diseases and genetic conditions; wound dressings; medical plasters; antiseptic wipes; diagnostic reagents for medical use except in connection with immunohematology and transfusion medicine containing any of the aforesaid products; food intolerance test kits comprising diagnostic test patches for application to the skin for determining allergies; reagents, namely, protein binding agents for use in scientific research; reagents, namely, protein binding agents for use in scientific screening; genetic testing kits comprised of reagents for medical purposes; genetic testing kits comprised of reagents for medical purposes for animals; genetic testing kits comprised of reagents for medical purposes; genetic testing kits comprised of reagents for medical purposes for animals

Owner

Prior registrations

Prosecution history

  • 05 Jul 2022 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
  • 04 Jul 2022 — ABANDONMENT - NO USE STATEMENT FILED
  • 04 Dec 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 02 Dec 2021 — SOU EXTENSION 3 GRANTED
  • 02 Dec 2021 — SOU EXTENSION 3 FILED
  • 02 Dec 2021 — SOU TEAS EXTENSION RECEIVED
  • 27 May 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 25 May 2021 — SOU EXTENSION 2 GRANTED
  • 25 May 2021 — SOU EXTENSION 2 FILED
  • 25 May 2021 — SOU TEAS EXTENSION RECEIVED
  • 03 Dec 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 01 Dec 2020 — SOU EXTENSION 1 GRANTED
  • 01 Dec 2020 — SOU EXTENSION 1 FILED
  • 01 Dec 2020 — SOU TEAS EXTENSION RECEIVED
  • 02 Jun 2020 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT

View this trademark record on Marksy